In vivo, oral administration of SDX increased the SOD activity and decreased the MDA level, infarct size and apoptosis of cardiomyocytes in a mouse model of MI/R Therefore, SDX may protect against MI/R injury by promoting the survival of cardiomyocytes. Here, SOD1 is linked to myocardial infarction.